[Therapy refractory depression--causes and treatment possibilities]. 1989

M Schmauss, and I Meller
Psychiatrische Klinik der Universität München.

Despite the advances in the treatment of depression, 10 to 30% of all depressions remain--depending on the definition of the term--refractory to treatment. Having clarified possible causes such as wrong diagnosis, poor compliance, inadequate treatment, drug interactions and psychological factors, various treatment methods can be applied. However it is necessary to know not only the efficacy but also the side effects and contraindications of these methods.

UI MeSH Term Description Entries
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

M Schmauss, and I Meller
June 1986, Fortschritte der Medizin,
M Schmauss, and I Meller
November 2023, Alpha psychiatry,
M Schmauss, and I Meller
March 1995, Psychiatrische Praxis,
M Schmauss, and I Meller
August 1998, Medizinische Monatsschrift fur Pharmazeuten,
M Schmauss, and I Meller
January 1999, Wiener medizinische Wochenschrift (1946),
M Schmauss, and I Meller
January 1983, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Schmauss, and I Meller
December 1992, Medizinische Monatsschrift fur Pharmazeuten,
M Schmauss, and I Meller
March 1982, L'union medicale du Canada,
M Schmauss, and I Meller
September 2014, Vnitrni lekarstvi,
M Schmauss, and I Meller
January 1991, Medizinische Monatsschrift fur Pharmazeuten,
Copied contents to your clipboard!